Cargando…
Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol
INTRODUCTION: Closed-loop systems titrate insulin based on sensor glucose levels, providing novel means to reduce the risk of hypoglycaemia while improving glycaemic control. We will assess effectiveness of 6-month day-and-night closed-loop insulin delivery compared with usual care (conventional or...
Autores principales: | Musolino, Gianluca, Allen, Janet M, Hartnell, Sara, Wilinska, Malgorzata E, Tauschmann, Martin, Boughton, Charlotte, Campbell, Fiona, Denvir, Louise, Trevelyan, Nicola, Wadwa, Paul, DiMeglio, Linda, Buckingham, Bruce A, Weinzimer, Stuart, Acerini, Carlo L, Hood, Korey, Fox, Steven, Kollman, Craig, Sibayan, Judy, Borgman, Sarah, Cheng, Peiyao, Hovorka, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561428/ https://www.ncbi.nlm.nih.gov/pubmed/31164368 http://dx.doi.org/10.1136/bmjopen-2018-027856 |
Ejemplares similares
-
Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020) -
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
por: Hood, Korey K., et al.
Publicado: (2022) -
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
por: Tauschmann, Martin, et al.
Publicado: (2018) -
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol
por: Fuchs, Julia, et al.
Publicado: (2021) -
Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol
por: Bally, Lia, et al.
Publicado: (2017)